University of Dundee

CLS Impact and Outreach

Silent Signal Preview

‘Silent Signal’ – an exhibition travelling to LifeSpace

The new exhibition opening at LifeSpace Science Art Research Gallery at the School of Life Sciences, University of Dundee, features six artworks commissioned by Animate Projects.

Dundee is Scottish University of the Year – again!

The University of Dundee has been named Scottish University of the Year in The Times and Sunday Times Good University Guide for a second consecutive year.

Dundee has been hailed for excellent teaching quality and student experience, being placed in the top ten in the UK for both key measures in the Good University Guide analysis. The Guide also noted the strength of research at the University and the institution’s economic, social and cultural impact.

Award-winning academia-industry collaboration attracts multi-million pound investment to accelerate drug discovery

The University of Dundee has announced renewed funding of more than £7million from three of the world’s leading pharmaceutical companies to support its Division of Signal Transduction Therapy (DSTT).

Pharmaceutical giants Boehringer Ingelheim, GlaxoSmithKline and Merck will provide support of £7.2 million until 2020, enabling scientists at Dundee to continue their fundamental research in multiple therapeutic areas, including cancer, arthritis, lupus, hypertension and Parkinson’s disease. This new round of funding secures 38 posts at Dundee for the next four years.

Dundee researchers contribute to `open science’ project to develop malaria drugs

Malaria remains one of the world’s leading causes of mortality in developing countries. Last year alone, it killed more than 400,000 people, mostly young children. This week in ACS Central Science, an international consortium of researchers, including scientists at the University of Dundee, unveils the mechanics and findings of a unique “open science” project for malaria drug discovery that has been five years in the making.

Cafe Science with Dr Marios Stavridis

In the last 10-15 years stem cells have been catapulted from a relatively obscure research topic to the international limelight. Hardly a week goes by without some news story about a “ground breaking discovery” or “exciting new therapy” involving stem cells. Are these cells really as exciting as people think? What are they, where do they come from and how are they used in modern medicine? Why are private stem cell clinics springing up all over the world, and can they really deliver on their promises? What about the ethics of stem cell research?  

Dundee team develops new diagnostic for animal trypanosomiasis

The cattle disease nagana, also called African animal trypanosomiasis, caused by the parasites Trypanosoma vivax and Trypanosoma congolense, affects huge swathes of sub-Saharan Africa, and the T. vivax disease has also spread to South America. With around 60 million cattle at risk from the disease, which causes muscle wasting and death, the socio-economic impacts of T. vivax infections in livestock are profound.

OME receives £1.4M Biomedical Resource Award

The OME Team has been awarded a £1.4M Biomedical Resource Award from the Wellcome Trust to extend the capabilities of its Bio-Formats image file reading library.  On receiving the award, Jason Swedlow, Professor of Quantitative Cell Biology and co-founder of OME said “the award is a recognition of the continuing growth of quantitative imaging in the life and biomedical sciences and the scientific community’s need for open source, community-driven tools for handling large, multidimensional image data sets.

Tenovus Scotland awards research grant to Dundee scientist for exciting research on Inflammasomes

Dr Sambit Nanda, a senior research scientist in the Medical Research Council’s Protein Phosphoryation and Ubiquitylation Unit (MRC-PPU) at the University of Dundee, has been awarded a research grant of £15,000 from Tenovus, Scotland to continue his exciting new research on inflammasomes.

Greg Findlay group identifies key regulator of stem cell identity with implications for cardiac patients

Scientists from the University of Dundee have discovered a key regulator of embryonic stem cell identity, research that could one day lead to new treatments for heart attack patients and those with congenital heart conditions.

Embryonic stem cells have the potential to provide tissue replacement therapies for a number of debilitating diseases due to their capacity to differentiate into any cell type in the adult body, a property known as pluripotency.